HBcAb-positive, HBsAg-negative people with HIV can safely switch from tenofovir-containing ART without clinically significant HBV reactivation.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/hbv-reactivation-risk-low-after-tenofovir-cessation-hiv-2025a1000smx?src=rss
Author :
Publish date : 2025-10-22 12:57:00
Copyright for syndicated content belongs to the linked Source.